Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes

Patent 10130707 was granted and assigned to Novaliq on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Novaliq
0
Date Filed
May 24, 2012
0
Date of Patent
November 20, 2018
0
Patent Application Number
14122044
0
Patent Citations Received
‌
US Patent 12128010 Semifluorinated compounds and their compositions
0
‌
US Patent 11679101 Anhydrous compositions of mTOR inhibitors and methods of use
0
‌
US Patent 11400132 Ophthalmic compositions comprising ciclosporin
‌
US Patent 11413323 Ophthalmic composition for treatment of dry eye disease
‌
US Patent 11987623 Stabilized antibody compositions
0
‌
US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes
0
‌
US Patent 12059449 Ophthalmic composition for treatment of dry eye disease
0
‌
US Patent 11510855 Topical sunscreen formulation
‌
US Patent 10722499 Anyhydrous compositions of mTOR inhibitors and methods of use
‌
US Patent 10813999 Topical pharmaceutical composition based on semifluorinated alkanes
0
•••
Patent Inventor Names
Bastian Theisinger
0
Dieter Scherer
0
Sonja Theisinger
0
Bernhard Gunther
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10130707
0
Patent Primary Examiner
‌
Layla Soroush
0

Find more entities like US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.